HB 712
Acts of Assembly Chapter text (CHAP0207)
Office-based buprenorphine treatment; Board of Medicine to amend regulations.
- Virginia
- House / Assembly
- Introduced Jan 13, 2026
- Session 2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Virginia’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
26 actions-
Acts of Assembly Chapter text (CHAP0207)
-
Approved by Governor-Chapter 207 (effective 7/1/2026)
-
Governor's Action Deadline 11:59 p.m., April 13, 2026
-
Enrolled Bill communicated to Governor on March 10, 2026
-
Fiscal Impact Statement from Department of Planning and Budget (HB712)
-
Signed by President
-
Signed by Speaker
-
Bill text as passed House and Senate (HB712ER)
-
Enrolled
-
Passed Senate (38-Y 0-N 0-A)
-
Read third time
-
Passed by for the day (Voice Vote)
-
Constitutional reading dispensed (on 2nd reading) (40-Y 0-N 0-A)
-
Rules suspended
-
Reported from Education and Health (13-Y 0-N)
-
Referred to Committee on Education and Health
-
Constitutional reading dispensed (on 1st reading)
-
Read third time and passed House (99-Y 0-N 0-A)
-
Read second time and engrossed
-
Read first time
-
Reported from Health and Human Services (22-Y 0-N)
-
Subcommittee recommends reporting (10-Y 0-N)
-
Assigned sub: Health Professions
-
Fiscal Impact Statement from Department of Planning and Budget (HB712)
-
Referred to Committee on Health and Human Services
-
Prefiled and ordered printed; Offered 01-14-2026 26104755D